Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 25.34% Profit

May 09, 2025
REGENERON PHARMACEUTICALS, INC. (REGN) saw its stock price hitting the target forecast provided by QuantWave on May 9, 2025, resulting in a profit of 25.34%. The forecast, which was issued on February 26, 2025, predicted a short direction for the stock when it was trading at $704.83. The stock reached the forecasted price of $526.2 on the target date, allowing investors to capitalize on the predicted movement.

This successful forecast highlights the accuracy and reliability of QuantWave's analytics in predicting stock movements. Factors contributing to the stock's decline could include macroeconomic trends, company-specific news, or industry developments. QuantWave's platform leverages advanced algorithms and machine learning techniques to provide users with actionable forecasts, helping them make informed investment decisions.

QuantWave offers a range of forecasting opportunities for various stocks, enabling investors to potentially profit from market movements. Investors interested in refining their investment strategy can explore QuantSchool, an educational resource providing insight into using QuantWave effectively. QuantSchool equips investors with the tools and knowledge needed to generate consistent income using QuantWave's forecasting system.

With QuantWave's accurate predictions and QuantSchool's educational resources, investors can enhance their investment approach and navigate the financial markets with confidence.
If you want to leave a comment, then you need Login or Register





Other data for REGN

Related data

REGNSeptember 5, 2025Regeneron Pharmaceuticals Inc. Continues to Impress Investors with Strong Performance  ~1 min.

Regeneron Pharmaceuticals Inc. (REGN) has been making waves in the stock market recently, with Evercore ISI maintaining a buy rating and a price target of 750....


REGNJuly 5, 2025Regeneron Pharmaceuticals: Revolutionizing Healthcare with Innovative Drug Approvals  ~1 min.

Regeneron Pharmaceuticals, Inc. recently made headlines with the approval of Dupixent by the US FDA, in collaboration with Sanofi....


REGNJune 27, 2025Regeneron Pharmaceuticals Inc. Continues to Impress Investors as UBS Lowers Price Target  ~1 min.

Regeneron Pharmaceuticals Inc. has been making waves in the biotech industry, with impressive financial and operating results....


REGNJune 5, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 33.76% Profit Margin  ~1 min.

QuantWave's forecast signal for REGENERON PHARMACEUTICALS, INC. on December 13, 2024, predicted a short direction with a price of 728.18 $. On June 5, 2025, the stock reached the target price of 482....


REGNJune 5, 2025REGENERON PHARMACEUTICALS, INC. Hits Forecast Price Target with a 32.0% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the forecast price target set by QuantWave, resulting in a profit of 32.0%. The forecast signal was issued on December 31, 2024, with a price of $709....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit  ~2 min.

REGENERON PHARMACEUTICALS, INC. (REGN) has successfully reached the price target forecast set by QuantWave, resulting in a profit of 27.18%....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with Profit of 26.25%  ~1 min.

REGENERON PHARMACEUTICALS, INC. stock recently achieved the price target forecast set by QuantWave on March 21, 2025. The forecast indicated a short direction, with the stock price at $657....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 26.25% Profit: QuantWave's Success in Stock Prediction  ~2 min.

REGENERON PHARMACEUTICALS, INC. has recently reached the price target forecast set by QuantWave on June 4, 2025....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. (ticker: REGN) has successfully achieved the price target forecast set by QuantWave, realizing a profit of 27.18%....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave's Price Target with 20.42% Profit  ~2 min.

In a recent success story for QuantWave, the automated forecasting platform accurately predicted a short position for REGENERON PHARMACEUTICALS, INC....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with a Profit of 30.6%  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecasted by QuantWave, resulting in a profit of 30.6% for investors who followed the short signal....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast on QuantWave with 16.34% Profit  ~2 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC. with a price target forecast of 571.74 $, signaling a potential 16....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 21.51% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, resulting in a profitable outcome for investors....


REGNOctober 31, 2024REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Price Target with Profit of 17.54%  ~2 min.

REGENERON PHARMACEUTICALS, INC. (stock ticker: REGN) recently saw its stock price hit the forecast target set by QuantWave, a leading automated forecasting platform....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave's Price Target Forecast with 16.89% Profit  ~1 min.

On January 14, 2025, QuantWave's automated forecasting platform issued a short signal for REGENERON PHARMACEUTICALS, INC. (stock ticker: REGN) with a target price of $571.74....